AES
51
-4
SWN
42
10
ECL
69
5
NTRS
37
15
SYY
50
6
CNX
36
-4
HBI
37
3
FSLR
63
-4
EXC
35
-2
GRMN
58
2
ABBV
68
2
CF
36
3
TAP
31
2
NWS
69
-4
MTCH
59
-7
XYL
47
6
WM
80
4
EA
49
3
SWKS
60
-5
WFC
58
3
AES
51
-4
SWN
42
10
ECL
69
5
NTRS
37
15
SYY
50
6
CNX
36
-4
HBI
37
3
FSLR
63
-4
EXC
35
-2
GRMN
58
2
ABBV
68
2
CF
36
3
TAP
31
2
NWS
69
-4
MTCH
59
-7
XYL
47
6
WM
80
4
EA
49
3
SWKS
60
-5
WFC
58
3
Financhill
Back

First Horizon Vs. Spyre Therapeutics Industry Stock Comparison

Sell
29

FHN
First Horizon

Last Price:
14.46
Seasonality Move:
0.66%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
29
First Horizon (FHN) is a Sell

Is First Horizon a Buy, Sell or Hold?

  • The current First Horizon [FHN] share price is $14.46. The Score for FHN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • FHN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FHN Stock Price Chart

What is First Horizon's stock price today?

  • The First Horizon share price today is $14.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FHN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

FHN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 33.99 Sell
Chaikin Money Flow: 5591671 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.95 - 16.01) Sell
Bollinger Bands (100): (14.17 - 15.53) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

FHN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.81 Sell
20-day SMA: 15.37 Sell
50-day SMA: 15.22 Sell
200-day SMA: 13.56 Buy
8-day EMA: 14.78 Sell
20-day EMA: 15.14 Sell
50-day EMA: 15.17 Sell
200-day EMA: 14.59 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

First Horizon Earnings Growth & FHN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.08 per share, and an increase next year of $0.13 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

First Horizon Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):